Welcome to the brain cancer page!

Whether you or someone you love has brain cancer, you've come to the right place!

Bookmark us now for the latest infomation on brain cancer research, brain cancer remedies, brain cancer risk, brain cancer prevention, screening, symptoms, diagnois, treatment and support for all people that have brain cancer

Brain Cancer Overview

Brain Cancer

The brain is the center of thought, emotion, memory, speech, and many more, and it is the most sophisticated organ in the human body. A hard skull protects the brain where it floats in a fluid called Cerebrospinal Fluid (CSF). The brain is generally set apart from the rest of the body, and functions rather differently too. Most of the brain cells are called astrocytes, and they basically support and serve the 10 billion working cells that are called neurons. These neurons make about 13 trillion connections with one another to sustain life within the human body.

Brain tumors can arise at any time and damage this complex organ in various ways. Some risk factors are environmental, like radiation from previous cancer treatment. Other risk factors are mainly due to immune system disorders, and rarely do they run in the family. Therefore, abnormalities of genes (mutations) are the main cause for brain cancer. It all starts in a single cell anywhere in the brain, since any type of cell there can become cancerous. Unlike cancer in other organs of the body, brain tumors spread locally and cause a lot of damage to the normal tissue in the place where they originated.

Most brain tumors are primary, and the two most common types are astrocytomas that start in the astrocytes, and glioblastomas multiforme. Primary brain tumors, which originate in or around the brain rarely spread to other another organ, though cancer in other organs, like the lungs, can spread or metastize to the brain. Such tumors are called metastic brain cancers and they are treated differently.

The symptoms or signs which hint to the existence of a brain tumor include:

* Blurred vision Personality changes Seizures Malaise Intellectual decline Headaches
* Vomiting Emotional liability Nausea

If a patient's symptoms suggest the presence of a brain tumor, a few examinations could be done. First, a physical examination is done, and the patient's complete medical history is studied. If there is a problem, imaging studies will show the tumor if it is present. Early detection and treatment usually don't affect the chances of survival. The two most common imaging studies used are the magnetic resonance imaging (MRI) and the computed tomography (CT) scan. The difference is that a CT is a type of cross-section X-ray, but an MRI uses strong magnets and radio waves instead. Other imaging studies like the position emission tomography (PET) and the angiography are less used because they only produce specific information dealing with certain aspects of a tumor.

All these examinations are then used to diagnose the tumor, but to achieve definite results, a biopsy is needed where a neurosurgeon removes some of the cancerous tissue for examination under a microscope to determine the best treatment and the chances of survival.

Due to the unique characteristics of brain cancer, treatment is extremely difficult and a cure is not possible since it would have to (1) treat the whole brain, (1) get to places where the blood flow does not reach, (3) kill every single cancerous cell without damaging the rest of the functional brain.

Unfortunately, such a cure has yet to be discovered, and the best treatment nowadays is called standard therapy. First, surgery is performed removing about 90% of the tumor. Radiotherapy and Chemotherapy follow to achieve the maximum therapeutic benefit. Since most brain cancer is not caused by any definite causes, and occurs for no apparent reason, it cannot be prevented, especially in children (astrocytoma and the medulloblastoma).

Because many parts of the brain are essential to life, a tumor that starts in any of these areas may be impossible to remove, and can eventually be life threatening.

Tumor Clinical Features Treatment & Prognosis

Glioblastoma multiforme Presents commonly with nonspecific complaints and increased intracranial pressure. As it grows, focal deficits develop. Course is rapidly progressive, with poor prognosis. Total surgical removal is usually not possible, and response to radiation therapy is poor.

Astrocytoma Presentation similar to glioblastoma multiforme but course more protracted, often over several years. Cerebellar astrocytma, especially in children, may have a more benign course. Prognosis is variable. By the time of diagnosis, total excision is usually impossible; tumor often is not radiosensitive. In cerebellar astrocytoma, total surgical removal is often possible.

Medulloblastoma Seen most frequently in children. Generally arises from roof of fourth ventricle and leads to increased intracranial pressure accompanied by brain stem and cerebellar signs. May seed subarachnoid space. Treatment consists of surgery combined with radiation therapy and chemotherapy.

Ependymoma Glioma arising from the ependyma of a ventricle, especially the fourth ventricle; leads early signs of increased intracranial pressure. Arises also from central canal of cord. Tumor is not radiosensitive and is best treated surgically if possible.

Tumor Clinical Features Treatment & Prognosis

Brain stem glioma Presents during childhood with cranial nerve palsies and then with long-tract sings in the limbs. Signs of increased intracranial pressure occur late. Tumor is inoperable; treatment is by irradiation and shunt for increased intracranial pressure.

Cerebellar hemangioblastoma Presents with disequilibrium, ataxia of trunk or limbs, and signs of increased intracranial pressure. Sometimes familial. May be associated with retinal and spinal vascular lesions, polycythemia, and hypernephromas. Treatment is surgical.

Pineal tumor Presents with increased intracranial pressure, sometimes associated with impaired upward gaze (Parinaud's syndrome) and other deficits indicative of midbrain lesion. Ventricular decompression by shunting is followed by surgical approach of tumor; irradiation is indicated if tumor is malignant. Prognosis depends on histopathologic findings and extent of tumor.

Craniopharyngioma Originates from remnants of Rathke's pouch above the sella, depressing the optic chiasm. May present at any age but usually in childhood, with endocrine dysfunction and bitemporal field defects. Treatment is surgical, but total removal may not be possible.

Acoustic neurinoma Ipsilateral hearing loss is most common initial symptom. Subsequent symptoms may include tinnitus, headache, vertigo, facial weakness or numbness, and long-tract signs. (May be familial and bilateral when related to neurofibromatosis.) Most sensitive screening tests are MRI and brain stem auditory evoked potential. Treatment is excision by translabyrinthine surgery, craniectomy, or combined approach. Outcome is usually good.

Meningioma Originates from the dura mater or arachnoid; compresses rather than invades adjacent neural structures. Increasingly common with advancing age. Tumor size caries greatly. Symptoms vary with tumor site. Tumor is usually benign and readily detected by CT scanning; may lead to calcification and bone erosion visible on plain x-rays of skull. Treatment is surgical. Tumor may recur if removal is incomplete.

Primary cerebral lymphoma Associated with AIDS and other immunodeficient states. Presentation may be with focal deficits or with disturbances of cognition and consciousness. May be indistinguishable from cerebral toxoplasmosis. Treatment is by whole-brain irradiation; chemotherapy may gave an adjunctive role. Standard Therapy

To date, the best treatment for malignant astrocytoma and glioblastoma multiforme (GBM) is a combination of:

* Surgery (Gross total removal, i.e. 80 - 99%)
* Radiotherapy (5,000 - 6,000 Rads)
* Chemotherapy (BCNU)
* Growth Dynamics (GBM):
* Growth Fraction = 20% (Only a percentage of the tumor is growing at any one time)
* Cell Cycle Time = 2 - 5 Days (This is how long it takes a growing cell to reproduce) *
* Cell Loss = 80 - 90% (A high percentage of cells spontaneously die off)
* Doubling Time = Around 7 Days




Brain Cancer News

5 Oct 2009 at 10:00pm
(American Association for Cancer Research) While little is known about the causes of glioma, researchers at the National Cancer Institute have found that this rare but often deadly form of brain cancer may be linked to early life physical activity and height.
26 Oct 2009 at 7:36am
Drug developer Antigenics Inc. said researchers at the University of California, San Francisco, reported positive results stemming from a study using its cancer therapy Oncophage to treat brain-cancer patients.
3 Nov 2009 at 7:00am
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
11 Jan 2010 at 10:00pm
(University of Utah Health Sciences) Brain cancer is the leading cause of cancer death in children. Now a more accurate diagnosis of childhood brain cancers may soon be possible, according to researchers at Huntsman Cancer Institute at the University of Utah. The information is published online today in the journal Cancer Research.
13 Dec 2009 at 10:00pm
(University of California - Los Angeles) Inhibiting fatty acid synthesis in brain cancer cells may offer a new option to treat about 50 percent of deadly glioblastomas that are driven by amplified signaling of the epidermal growth factor receptor, according to a first-of-its-kind study by researchers at UCLA's Jonsson Comprehensive Cancer Center.
18 Jan 2010 at 10:00pm
(NIH/National Human Genome Research Institute) The most common form of malignant brain cancer in adults, glioblastoma multiforme (GBM), is not a single disease but appears to be four distinct molecular subtypes, according to a study by the Cancer Genome Atlas (TCGA) Research Network.
27 Jan 2010 at 10:00pm
Researchers at UCLA's Jonsson Comprehensive Cancer Center have performed the first complete genomic sequencing of a brain cancer cell line, a discovery that may lead to personalized treatments based on the unique biological signature of an individual's cancer and a finding that may unveil new molecular targets for which more effective and less toxic drugs can be developed.
14 Jan 2010 at 10:00pm
(University of Texas M. D. Anderson Cancer Center) Cancer-initiating cells that launch glioblastoma multiforme, the most lethal type of brain tumor, also suppress an immune system attack on the disease, scientists from the University of Texas M. D. Anderson Cancer Center report in a paper featured on the cover of the Jan. 15 issue of Clinical Cancer Research.
21 Dec 2009 at 11:59am
Agios Pharmaceuticals has received a $180,000 grant from the non-profit organization Accelerate Brain Cancer Cure.
16 Nov 2009 at 10:46pm
Dr. Howard Riina looking at scans during a procedure performed on Dennis Sugrue, 50, who has glioblastoma, the cancer that Senator Edward M. Kennedy of Massachusetts had.An experimental treatment for glioblastoma suppresses a barrier to deliver a drug directly to brain tumors.
6 Dec 2009 at 10:00pm
Scientists have discovered oncogenes capable of driving growth of normal human brain stem cells in a highly malignant pediatric brain tumor. The research, published by Cell Press in the December issue of the journal Cancer Cell, has significant implications for clinical management of aggressive pediatric brain tumors that are notorious for their dismal prognosis.
2 Dec 2009 at 10:00pm
(Howard Hughes Medical Institute) Howard Hughes Medical Institute researchers have identified a new factor that is necessary for the development of many forms of medulloblastoma, the most common type of malignant childhood brain cancer.
10 Oct 2009 at 3:00am
A team of researchers led by The University of Texas M. D. Anderson Cancer Center unveiled results today from the largest-ever collaborative study addressing the treatment of a rare pediatric brain tumor.
5 Jan 2010 at 11:48am
The Kennedy Krieger Institute has won a $1.5 million grant from a science foundation to perform brain cancer research.
3 Jan 2010 at 10:00pm
(UT Southwestern Medical Center) An experimental drug currently being tested against breast and lung cancer shows promise in fighting the brain cancer glioblastoma and prostate cancer, researchers at UT Southwestern Medical Center have found in two preclinical studies.